The production value of basic pharmaceutical products and pharmaceutical preparations in Austria has generally shown an upward trend from 2013 to 2023, registering consistent growth with occasional minor setbacks. In 2023, the value stood at 5.41 billion Euros. Significantly, the sector hit a growth acceleration phase around 2018 with a notable jump in 2019 of 11.46%. Despite a slight decline in 2020, the market rebounded and continued steady growth through 2023.
Recent trends indicate a year-on-year increase of 3.66% from 2022 to 2023. The 5-year compound annual growth rate (CAGR) from 2018 to 2023 is 3.84%. Looking ahead, the forecasted growth rate from 2024 to 2028 is slightly conservative, pegged at 2.51% CAGR, with an overall 5-year growth rate of 13.18%.
Future trends to watch for include:
- Advancements in biotechnology and personalized medicine driving production values higher.
- Potential market disruptions from global economic changes or healthcare policies.
- The impact of increased investments in R&D and innovation within the pharmaceutical sector.
